| Medicare Noridian | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (57423) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: MGMT Promoter Methylation Analysis (57432) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (57441) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: EndoPredict– Breast Cancer Gene Expression Test (57607) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma) (57621) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Inivata–, InVisionFirst–, Liquid Biopsy for Patients with Lung Cancer (57664) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Breast Cancer Index– (BCI) Gene Expression Test (57773) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (58718) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (59032) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (59179) | 2026-01-12 |